​

Accelerate Diagnostics (AXDX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AXDX Stock Rating

Accelerate Diagnostics stock's rating consensus is Hold, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (25.00%), 2 Hold (50.00%), 1 Sell (25.00%), and 0 Strong Sell (0.00%).

Hold
Total 4 0 1 2 1 Strong Sell Sell Hold Buy Strong Buy

AXDX Price Target Upside V Benchmarks

TypeNameUpside
StockAccelerate Diagnostics-
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.18%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.03$0.03$0.03
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-1---1
Mar, 25-1---1
Feb, 25-1---1
Jan, 25-1---1
Dec, 24-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 25, 2022William BlairOutperformOutperformhold

Financial Forecast

EPS Forecast

$-15 $-12 $-9 $-6 $-3 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-13.96$-12.59$-7.61$-4.94$-2.15--
Avg Forecast$-13.88$-11.53$-7.78$-4.83$-2.30$-2.00$-0.36
High Forecast$-13.88$-11.53$-7.78$-4.83$-2.30$-2.00$-0.36
Low Forecast$-13.88$-11.53$-7.78$-4.83$-2.30$-2.00$-0.36
Surprise %0.58%9.19%-2.19%2.28%-6.52%--

Revenue Forecast

$10M $13M $16M $19M $22M $25M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$11.16M$11.78M$12.75M$12.06M$11.70M--
Avg Forecast$12.09M$11.85M$12.66M$12.46M$11.90M$12.30M$22.40M
High Forecast$12.09M$11.85M$12.66M$12.46M$11.90M$12.30M$22.40M
Low Forecast$12.09M$11.85M$12.66M$12.46M$11.90M$12.30M$22.40M
Surprise %-7.67%-0.57%0.71%-3.24%-1.70%--

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-78.21M$-77.70M$-62.49M$-61.62M$-50.05M--
Avg Forecast$-76.49M$-143.80M$-82.23M$-61.62M$-28.70M$-24.95M$-4.49M
High Forecast$-61.19M$-143.80M$-65.78M$-49.29M$-28.70M$-24.95M$-4.49M
Low Forecast$-91.79M$-143.80M$-98.68M$-73.94M$-28.70M$-24.95M$-4.49M
Surprise %2.25%-45.96%-24.00%-74.39%--

AXDX Forecast FAQ

Is Accelerate Diagnostics stock a buy?

Accelerate Diagnostics stock has a consensus rating of Hold, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Accelerate Diagnostics is a neutral investment for most analysts.

What is Accelerate Diagnostics's price target?

Accelerate Diagnostics's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $0.03.

How does Accelerate Diagnostics stock forecast compare to its benchmarks?

Accelerate Diagnostics's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (20.18%).

What is the breakdown of analyst ratings for Accelerate Diagnostics over the past three months?

  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Accelerate Diagnostics’s EPS forecast?

Accelerate Diagnostics's average annual EPS forecast for its fiscal year ending in December 2025 is $-2, marking a -6.98% decrease from the reported $-2.15 in 2024. Estimates for the following years are.

What is Accelerate Diagnostics’s revenue forecast?

Accelerate Diagnostics's average annual revenue forecast for its fiscal year ending in December 2025 is $12.3M, reflecting a 5.15% increase from the reported $11.7M in 2024. The forecast for.

What is Accelerate Diagnostics’s net income forecast?

Accelerate Diagnostics's net income forecast for the fiscal year ending in December 2025 stands at $-24.954M, representing a -50.14% decrease from the reported $-50.045M in 2024. Projections indicate .